Nimbolide upregulates RECK by targeting miR-21 and HIF-1α in cell lines and in a hamster oral carcinogenesis model. [electronic resource]
- Scientific reports 05 2017
- 2045 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't